303 articles from
- AI In Practice
- Alternatives
- Analysis
- Asia In Focus
- Asset Allocation
- Clients
- Comings & Goings
- Commercial Property
- Compliance
- Daily Market Update
- Defensive Assets
- ETF
- Fintech
- Funds In Focus
- Growth Assets
- INDepth
- Industry Governance
- Industry Profiles
- Infrastructure
- Insurance / Risk
- Intergen Wealth Transfer
- Investment
- Networking / Social
- Operations
- Portfolio Construction Strategy
- Practice Growth
- Private Debt & Equity
- Purchase, Merger Sale Of Practice
- Real Assets
- Reporting Season
- SMSF
- Succession Planning
- Superannuation
- Tax
- Teams
- Technology
- Usa In Focus
- Young Professionals
Vaccines to the rescue, says Atchison, but how much optimism is baked-In?
Asset consultancy Atchison Consultants expects 2021 to be a “recovery year” on global markets, based on the prospects for the COVID-19 vaccines...
Australian Unity issues Australian-first MCI
With interest rates at all-time lows, and term deposits lucky to be paying 0.5%, investors have simply been forced to look for alternative income-generating...
Taking a 'whole of Asia' view in the booming small-cap universe
One of the more impressive funds that The Inside Network has come across in recent years is the PineBridge Asia ex Japan Small Cap Equity Fund, which taps into...
Thinking forward: Three ASX biotech stars
And still they keep coming – here’s the fourth instalment of our series on the fascinating ASX cohort of medical device developers. As always,...
Spatium's secret small cap sauce
Four years ago, old high-school buddies Nicholas Quinn and Jesse Moors were taking in the sunshine at a café on Melbourne’s Southbank, when they...
Will $5.20 Fill the Missing Link?
Shareholders of Link Administration Holdings (LNK), which provides services to the funds management and superannuation sectors and runs the share registry for...
Battleground: BHP vs RIO
Big Australian Wins Battle of the Bulks OK, so you want to own a big global diversified bulk miner, to take advantage of the impending commodities boom –...
Thinking ahead - ASX MedTech leaders
Here’s the fourth instalment of our series on the fascinating ASX cohort of medical device developers. ImpediMed (IPD, 8.1 cents)Market capitalisation:...
Riding for charity with Invesco
Like everyone, Eben Bowditch, head of sales at Invesco Australia, was trying to navigate the abnormal and difficult times of the COVID-19 pandemic and...
Playing Tesla's battery day via ETFs
One of the great investment success stories of the last 25 years has been the exchange-traded fund (ETF), which got under way in the early 1990s as a vehicle...
Lendi Listing Looks for Loan Liftoff
Another fintech is heading for the ASX screens, with online mortgage provider Lendi poised to push “go” on an initial public offering (IPO) that...
Device Stars Part 3
4DMedical (4DX, $1.58)Market capitalisation: $418 millionThree-year total return: n/aAnalysts’ consensus target price: $1.70 (Thomson Reuters) Imaging...
Backing Buffett's Big Japan Bet
It seems as if Japan does not get a lot of respect from external investors, for good reasons. The Nikkei index appears to disprove the theory that the...
Semi-Loved and Semi-Understood - but Semiconductors Rule
Semiconductors would have to be one of the most pervasive and critical pieces of technology in our daily lives – but they are usually not thought about...
Get to know Troy Armstrong from Koda Capital
Troy is a Partner and Adviser at Koda Capital. Troy is a FASEA-compliant financial adviser holding a Bachelor of Commerce and SMSF Specialist Adviser...
